Neumora Therapeutics, Inc. (NMRA)
0.4757
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.4739
0.00 (0.00%)
After-Hours: 20:00
Neumora Therapeutics Shareholders Equity (Quarterly) : 44.52M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.52M |
| March 31, 2026 | 70.68M |
| December 31, 2025 | 103.87M |
| September 30, 2025 | 132.16M |
| June 30, 2025 | 182.88M |
| March 31, 2025 | 228.36M |
| December 31, 2024 | 287.06M |
| September 30, 2024 | 320.74M |
| June 30, 2024 | 381.26M |
| Date | Value |
|---|---|
| March 31, 2024 | 424.54M |
| December 31, 2023 | 469.08M |
| September 30, 2023 | 512.69M |
| June 30, 2023 | 330.15M |
| March 31, 2023 | 365.77M |
| December 31, 2022 | 396.84M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 363.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioAge Labs, Inc. | 374.91M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 125.25M |
| Total Liabilities (Quarterly) | 80.73M |
| Debt to Equity Ratio | 1.196 |
| Current Ratio | 4.496 |
| Net Debt Paydown Yield | -3.29% |